According to Next Move Strategy Consulting, the global Conductive and Contactless EEG Market, a crucial segment within the neurodiagnostic devices industry, is experiencing significant growth, driven by technological advancements, the increasing prevalence of neurological disorders, and the expanding applications of electroencephalogram (EEG) technology in both clinical and research settings.
Explore the Benefits with a FREE Sample!
Market Overview
The conductive and contactless EEG market is focused on the development, production, and distribution of devices that measure and record brain activity. EEG technology is used extensively to diagnose, monitor, and treat a variety of neurological conditions by capturing the electrical activity of the brain. There are two primary types of EEG devices: conductive and contactless.
Conductive EEG Devices: These systems use electrodes that make direct contact with the scalp, providing highly accurate data for clinical applications. They are primarily employed in hospital settings, research labs, and surgical environments to diagnose and monitor conditions such as epilepsy, sleep disorders, and neurodegenerative diseases.
Contactless EEG Devices: These cutting-edge systems detect brain activity without direct contact with the scalp, using advanced sensors and signal processing technologies. Contactless EEG devices are gaining popularity due to their comfort, ease of use, and ability to facilitate continuous monitoring, including home-based applications. These systems have substantial potential in brain-computer interface (BCI) research and the development of neurotechnology solutions.
Try it Risk-Free – Download Your FREE Sample!
The growing demand for EEG devices is driven by the need for effective diagnostic tools to manage neurological disorders, the rise of brain-computer interface technologies, and the increasing focus on personalized healthcare.
Market Dynamics and Trends
Rising Prevalence of Neurodegenerative Diseases
One of the key factors fueling the growth of the conductive and contactless EEG market is the increasing prevalence of neurodegenerative diseases, particularly Parkinson’s disease. According to the Parkinson’s Foundation, it is estimated that 1.2 million people in the U.S. will be living with Parkinson’s disease by 2030. This surge in prevalence is creating a significant demand for sophisticated neurodiagnostic solutions to improve disease management, track progression, and assess the efficacy of treatments.
EEG technology plays a critical role in the early detection of neurodegenerative diseases, monitoring disease progression, and evaluating the effects of treatment. Conductive EEG systems provide precise data for clinical applications, while contactless EEG systems offer non-invasive, comfortable monitoring options, which are essential for patients in home care settings.
Aging Population
The global aging population is another factor contributing to the market’s growth. With a rising number of elderly individuals, particularly those over the age of 60, there is a greater need for technologies that can monitor and manage age-related neurological disorders such as Alzheimer’s disease and other forms of dementia. The World Health Organization (WHO) predicts that the global population aged 60 years and older will reach 1.4 billion by 2030 and double by 2050. This demographic shift is expected to drive the demand for EEG systems to detect and monitor neurological conditions in the elderly, thus expanding the market.
Integration with Brain-Computer Interfaces (BCI)
The seamless integration of contactless EEG systems with brain-computer interfaces is opening new avenues for innovation in the market. BCIs use brain signals to control external devices such as prosthetic limbs, computer interfaces, and assistive technologies. As contactless EEG systems advance, they offer greater potential for real-time applications, enabling users to control devices through thought alone. This presents immense growth opportunities, especially in the fields of rehabilitation and assistive technology.
Market Segmentation
The conductive and contactless EEG market is segmented based on product type, application, end-user, and region.
By Product Type:
- EEG Equipment
- EEG Accessories
By Application:
- Disease Diagnosis
- Sleep Monitoring
- Anesthesia Monitoring
- Trauma & Surgery
- Others
By End-User:
- Hospitals
- Diagnostic Centers
- Ambulatory Surgical Centers
- Research Laboratories
- Others
By Region:
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Geographical Analysis
North America: Market Leader
North America dominates the conductive and contactless EEG market, driven by an increase in investments and initiatives aimed at enhancing the diagnosis and treatment of neurological disorders. In particular, the U.S. has witnessed a significant rise in the demand for EEG systems due to the increasing rate of Alzheimer’s disease and other neurological conditions. In 2022, the Alzheimer’s Disease Association reported that approximately 2 million people in the U.S. were affected by Alzheimer’s, highlighting the need for improved diagnostic solutions.
Furthermore, companies in North America, such as Neuronetics Inc., are making substantial investments in research and development, contributing to the market’s growth. For example, Neuronetics launched the NeuroStar Advanced Therapy in 2023, a non-invasive treatment designed to improve the quality of life for individuals suffering from neurohealth conditions, including major depressive disorder and anxious depression. This innovation directly contributes to the demand for advanced neurodiagnostic devices, including EEG technology.
Europe: Growing Investment in Neuroscience Research
Europe is witnessing steady growth in the conductive and contactless EEG market, fueled by government initiatives and interdisciplinary collaborations aimed at advancing brain health research. For example, the European Commission’s support for the European Brain Council’s initiative “Towards Structuring Brain Health Research in Europe” is promoting coordination among researchers, healthcare professionals, and industry stakeholders to accelerate brain-related studies.
In addition, an increasing number of healthcare institutions in Europe are integrating EEG systems into their diagnostic and monitoring practices, creating a favorable environment for market expansion.
Asia-Pacific: Surge in Medical Device Sector
The Asia-Pacific region is experiencing a rapid surge in demand for advanced medical devices, including EEG systems, driven by improving healthcare infrastructure and growing investments in healthcare technologies. The Indian government’s National Medical Devices Policy 2023, which aims to expand the medical device sector from USD 11 billion to USD 50 billion within the next five years, is expected to significantly boost access to EEG technology. Additionally, countries like China, Japan, and South Korea are seeing increased demand for neurodiagnostic solutions to address growing concerns over neurological conditions.
Competitive Landscape
The competitive landscape of the conductive and contactless EEG market includes several key players that are continually innovating to maintain their market leadership. Major companies in the market include:
- Advanced Brain Monitoring
- BioSemi
- Brain Products GmbH
- Nihon Kohden
- Electrical Geodesics, Inc.
- Natus Medical Incorporated
- NeuroWave Systems Inc.
- Medtronic
- Philips Healthcare
- Compumedics Limited
These companies are adopting various strategies, including product launches, partnerships, and acquisitions, to enhance their market presence. For example, in December 2023, Nihon Kohden introduced the One View feature in its Neuromaster G1 intraoperative neuromonitoring system. This innovation integrates anesthesia and vital signs with neurological data, offering enhanced functionality for real-time monitoring during surgeries.
In another development, Advanced Brain Monitoring (ABM) partnered with Stratus EEG in November 2023 to integrate its mobile wireless 24-channel EEG technology with Stratus’ cloud-based platform, further expanding the clinical applications of EEG in seizure and epilepsy monitoring.
Conclusion
The conductive and contactless EEG market is poised for substantial growth in the coming years, driven by the rising prevalence of neurological disorders, the aging global population, and technological innovations such as the integration of EEG systems with brain-computer interfaces. As demand for more advanced diagnostic and monitoring solutions grows, EEG technologies will play an increasingly important role in addressing healthcare needs across various regions.
